Skip to content

NTRB

NutriBand Inc.

NASDAQ · Healthcare · Biotechnology · US

$6.00
−3.54%
Ask drillr

Year over year

Reported trailing growth

Revenue
-37.3%
EBITDA
+31.8%
EBIT
-3.5%
EPS
+80.1%
Free cash flow
—
Operating cash flow
—

Forward estimates

Based on analyst estimates

Revenue
-10.7%
EBITDA
+17.1%
EPS
+16.8%

Three-year CAGR

Revenue
-0.7%
EBITDA
+21.3%
EBIT
-24.3%
Net income
+21.5%
EPS
—
Free cash flow
-8.8%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026